Picture of the pathogen
The Covid-19 disease has infected over 6 million people within its six months of diagnosis. The illness has taken above 365K lives till now. It has shattered the entire world and caused the world economy to succumb to decline. Over 110 groups have been trying hard to release an effective cure. As a result, hundreds of possible solutions such as an antigen test near me are in process, and some have reached advanced trial phases.

Where are we with the development?

We need to make it available to the mass. Only then, we can stop the outbreak. Let’s take a look at the progress made.

China’s Sinovac

Sinovac Biotech announces 99% efficiency of the possible solution they have produced. It is a Beijing-based biopharmaceutical company. They are on phase two based on 1000 volunteers. They aim to start the next process soon in the United Kingdom. In May 2020, they had shown success in saving monkeys from Covid using it. The company has secured $15 million in fundings. Thus it is aiming to speed up the production of the cure.

Moderna

Moderna is one of the front-liners of the run. It uses novel mRNA sequences in their antigen test near me to fight against the infected proteins. So our body can induce antibodies against the disease. According to Forbes, they will start phase 3 in July. They will conduct the study on 30000 patients. It will include both young and grown-up Americans. They have already completed step 2 of the mRNA-1273 and aim to start the final level soon. Moderna started testing its vaccine on March 16, 2020, on a volunteer in Seattle. NIAID is financing the research. So, the company can try if it is safe and can produce immunity in the body.

Oxford University

Oxford University had announced the trials of ChAdOx1 on April 23. They have focused on it in the TTR research. It is a weak flu pathogen that usually infects chimpanzees. They have changed the sequences of it. Thus it cannot replicate in human cells. The researchers have made genetic changes to it. The aim was to produce the glycoproteins of the disease. So the antibodies get exposed to the cure when it enters the body. Thus the body can recognize it and induce an effective immune system.

The first trial took place on over 1000 participants. They are now under observation. More than 320 people got injected with this medical option. Researchers have found this is indeed safe. But there are reports of side effects like fever, swelling, and headache. Serum Institute of India is assisting the research. Both aim to complete the production in October 2020. Reuters says that Brazil has approved the human examinations on June 5.

Novavax

Firstly, Novavax has used ‘recombinant protein nanoparticle technology’ to make the cure. It is a USA-based company. Secondly, since 25th May, they announced to start stage I/II in Australia. They have begun examinations of it on 131 participants for the first step. Their ages range between 18 to 59 years. To attain it, they shot 5mcg and 25mcg dosages with and without the adjuvant. Novavax centre assumes to get the results of this process in July 2020.  Lastly, the U.S. Department of Defense has announced a fund of up to $60 million for the vaccine.

Final Thought

The researchers have been trying medical options to make an efficient one. Thus the world will get relief from this pandemic if we come together and work for a cure. In the meantime, the experts advise the public to resort to an antigen test near me to make sure that they are free from the disease.